{"id":"W4285606218","doi":"10.1016/j.eururo.2022.06.009","title":"Health-related Quality of Life Analysis from KEYNOTE-426: Pembrolizumab plus Axitinib Versus Sunitinib for Advanced Renal Cell Carcinoma","year":2022,"lang":"en","type":"article","venue":"European Urology","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":36,"is_retracted":false,"has_abstract":false,"ca_institutions":"Centre Hospitalier de l’Université de Montréal; Université Laval","funders":"","keywords":"Medicine; Sunitinib; Axitinib; Renal cell carcinoma; Pembrolizumab; Internal medicine; Kidney cancer; Quality of life (healthcare); Hazard ratio; Oncology; Adverse effect; Cancer; Confidence interval; Urology","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.001023543,0.0003419431,0.001402453,0.0004207667,0.0002633842,0.000007861802,0.0003282042,0.00006986535,0.001066549],"category_scores_gemma":[0.0003545504,0.0003474621,0.0006405542,0.0006848658,0.0001570724,0.00003638286,0.0002823996,0.0004995465,0.00004671657],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0003451926,"about_ca_system_score_gemma":0.000457494,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001593059,"about_ca_topic_score_gemma":0.0001016209,"domain_scores_codex":[0.9944825,0.002284746,0.001369407,0.0007968973,0.0004588845,0.0006076139],"domain_scores_gemma":[0.9965628,0.001032699,0.0009112566,0.0009269689,0.0001659657,0.0004003576],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"observational","study_design_scores_codex":[0.6628939,0.007633764,0.09946676,0.001434476,0.01966725,0.004545871,0.02302458,0.08536847,0.05311035,0.002795185,0.01906432,0.0209951],"study_design_scores_gemma":[0.1114906,0.02692383,0.830428,0.00001107408,0.004944589,0.00007101768,0.002158228,0.002938976,0.002912174,0.0001184534,0.01705087,0.0009521623],"study_design_candidate":"observational","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9825591,0.002351983,0.0002907105,0.001852626,0.0004060304,0.0008272962,0.0007127363,0.00009978392,0.01089971],"genre_scores_gemma":[0.9945325,0.00001650665,0.000688171,0.001158488,0.000134806,0.00006574749,0.002639605,0.00009152717,0.0006726983],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.7309612,"threshold_uncertainty_score":0.9998977,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.05936434309129127,"score_gpt":0.3011600521554575,"score_spread":0.2417957090641662,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}